Literature DB >> 31098876

Multiple airborne allergen-induced eosinophilic chronic rhinosinusitis murine model.

Sang Chul Park1, Soo In Kim2,3, Chi Sang Hwang4, Hyung-Ju Cho1,3,5, Joo-Heon Yoon1,3,5,6, Chang-Hoon Kim7,8,9,10.   

Abstract

PURPOSE: Several murine models have been established to mimic human eosinophilic chronic rhinosinusitis (ECRS). However, in most of these models, ECRS was induced using ovalbumin, which does not cause sinusitis in humans. Thus, we aimed to develop a more clinically relevant murine model of ECRS using multiple airborne allergens. We also investigated the effects of exposure duration of the allergens on ECRS development.
METHODS: C57BL/6 mice were intranasally administered multiple airborne allergens (house dust mite, Aspergillus fumigatus, Alternaria alternata, and protease from Staphylococcus aureus) three times weekly for 4, 8, 12, and 16 consecutive weeks. Histopathological changes, the levels of cytokines and chemokines in the nasal lavage fluid, and immune cells of the blood and spleen were analyzed.
RESULTS: The mice administered multiple allergens showed significantly increased eosinophil infiltration, epithelial thickening and disruption, and subepithelial collagen deposition from 8 weeks compared to the control group. Goblet cell hyperplasia, polyp-like lesions, and blood eosinophils, as well as the levels of interleukin-5 and eotaxin in the nasal lavage fluid were considerably increased in the ECRS group from 12 weeks compared to those of controls. Instillation of allergens for 16 weeks exacerbated the eosinophil infiltration and eotaxin increase in the nasal lavage fluid.
CONCLUSIONS: We successfully established a new murine model of ECRS using more clinically relevant multiple airborne allergens. Prolonged exposure to airborne allergens for 12 weeks or more, corresponding to the definition of human ECRS, strongly induced eosinophil infiltration as well as epithelial remodeling.

Entities:  

Keywords:  Airborne allergen; Eosinophil; Epithelial remodeling; Murine model; Rhinosinusitis

Mesh:

Substances:

Year:  2019        PMID: 31098876     DOI: 10.1007/s00405-019-05465-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  48 in total

1.  Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.

Authors:  Nan Zhang; Thibaut Van Zele; Claudina Perez-Novo; Nicholas Van Bruaene; Gabriele Holtappels; Natalie DeRuyck; Paul Van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2008-09-19       Impact factor: 10.793

2.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

3.  Development of Aspergillus protease with ovalbumin-induced allergic chronic rhinosinusitis model in the mouse.

Authors:  Ji Heui Kim; Jong Sook Yi; Chang-Hoon Gong; Yong Ju Jang
Journal:  Am J Rhinol Allergy       Date:  2014 Nov-Dec       Impact factor: 2.467

Review 4.  Mouse models of allergic asthma: acute and chronic allergen challenge.

Authors:  Anthony T Nials; Sorif Uddin
Journal:  Dis Model Mech       Date:  2008 Nov-Dec       Impact factor: 5.758

5.  Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania.

Authors:  Xiangdong Wang; Nan Zhang; Mingyu Bo; Gabriele Holtappels; Ming Zheng; Hongfei Lou; Hong Wang; Luo Zhang; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2016-07-15       Impact factor: 10.793

6.  Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.

Authors:  Peter Tomassen; Griet Vandeplas; Thibaut Van Zele; Lars-Olaf Cardell; Julia Arebro; Heidi Olze; Ulrike Förster-Ruhrmann; Marek L Kowalski; Agnieszka Olszewska-Ziąber; Gabriele Holtappels; Natalie De Ruyck; Xiangdong Wang; Cornelis Van Drunen; Joaquim Mullol; Peter Hellings; Valerie Hox; Elina Toskala; Glenis Scadding; Valerie Lund; Luo Zhang; Wytske Fokkens; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2016-03-04       Impact factor: 10.793

7.  TGF-beta signaling and collagen deposition in chronic rhinosinusitis.

Authors:  Nicholas Van Bruaene; Lara Derycke; Claudina Angela Perez-Novo; Philippe Gevaert; Gabriele Holtappels; Natalie De Ruyck; Claude Cuvelier; Paul Van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2009-06-04       Impact factor: 10.793

8.  Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL/6 mice.

Authors:  R Khalmuratova; M Lee; D W Kim; J-W Park; H-W Shin
Journal:  Allergol Immunopathol (Madr)       Date:  2015-08-01       Impact factor: 1.667

9.  Characterization of a novel, papain-inducible murine model of eosinophilic rhinosinusitis.

Authors:  Anuj Tharakan; Alex Dobzanski; Nyall R London; Syed M Khalil; Nitya Surya; Andrew P Lane; Murugappan Ramanathan
Journal:  Int Forum Allergy Rhinol       Date:  2018-01-17       Impact factor: 3.858

10.  Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.

Authors:  T Tokunaga; M Sakashita; T Haruna; D Asaka; S Takeno; H Ikeda; T Nakayama; N Seki; S Ito; J Murata; Y Sakuma; N Yoshida; T Terada; I Morikura; H Sakaida; K Kondo; K Teraguchi; M Okano; N Otori; M Yoshikawa; K Hirakawa; S Haruna; T Himi; K Ikeda; J Ishitoya; Y Iino; R Kawata; H Kawauchi; M Kobayashi; T Yamasoba; T Miwa; M Urashima; M Tamari; E Noguchi; T Ninomiya; Y Imoto; T Morikawa; K Tomita; T Takabayashi; S Fujieda
Journal:  Allergy       Date:  2015-05-26       Impact factor: 13.146

View more
  3 in total

1.  The Role of Mesenchymal Stem Cells in the Treatment of a Chronic Rhinosinusitis-An In Vivo Mouse Model.

Authors:  Veronica-Elena Trombitaș; Alina Anda Nagy; Cristian Berce; Emoke Pall; Flaviu Tăbăran; Aranka Ilea; Silviu Albu
Journal:  Microorganisms       Date:  2021-05-30

Review 2.  Revisiting the controversy: The role of fungi in chronic rhinosinusitis.

Authors:  Matthew A Tyler; Kent Lam; Michael J Marino; William C Yao; Isaac Schmale; Martin J Citardi; Amber U Luong
Journal:  Int Forum Allergy Rhinol       Date:  2021-06-02       Impact factor: 3.858

3.  Development and immunopathological characteristics of an Alternaria-induced chronic rhinosinusitis mouse model.

Authors:  Seung-Heon Shin; Mi-Kyung Ye; Dong-Won Lee; Mi-Hyun Chae; Sung-Yong Choi
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.